TrakCel's cell therapy process management solution improves clinical
study efficacy and accelerates product scale-up/scale-out by
implementing communications technology to integrate the supply chain
from end-to-end. The technology provides interactive instructions to
professionals within the cell therapy supply chain and gives
stakeholders on-demand visibility of procedural results and
chain-of-custody data for immediate traceability, validation and
compliance audits. Founded in 2012, TrakCel technology has been adopted
by GlaxoSmithKline and other leaders in the cell therapy industry.
TrakCel is based in Cardiff, Wales, UK.